The Potential Impact of Histamine-2 Receptor Antagonists on Gynecologic Cancer Risk: A Population-Based Study of 23 Million Individuals.

Saved in:
Bibliographic Details
Title: The Potential Impact of Histamine-2 Receptor Antagonists on Gynecologic Cancer Risk: A Population-Based Study of 23 Million Individuals.
Authors: Chiang CJ; School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Nguyen NTH; Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.; School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan., Huang CW; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Nguyen PA; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Research Center of Healthcare Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan., Wang SF; School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Wang CH; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Hung FH; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan., Lin GL; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Liu YC; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan., Yang HC; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Research Center of Healthcare Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.; Research Center of Big Data and Meta-Analysis, Taipei Municipal Wanfang Hospital, Taipei Medical University, Taipei, Taiwan.
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2026 Apr 01; Vol. 35 (4), pp. 540-547.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7755
DOI:10.1158/1055-9965.EPI-25-1306